RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

P.E.I.’s Chief Public Health Officer is working towards expanding eligibility for RSV vaccines as the province experiences ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

With the triad of respiratory viruses present in our day-to-day, it is recommended that individuals receive both COVID-19, flu, and occasionally RSV and MPox vaccinations. However, there is a common ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Dr. Ben Weston, chief health policy advisor for Milwaukee County, joins Lake Effect's Joy Powers to talk about how you can ...